A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2018 - Taylor & Francis
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
Reactogenicity and Safety of DTPa Vaccine and Haemophilus influenzae Type b Conjugate Vaccine (Hib) in a Single Injection vs DTPw and Hib as Separate …
J Arístegui, P García-Corbeira, J De la Flor… - Clinical Drug …, 2001 - Springer
Objective To compare the reactogenicity and safety of the administration of diphtheria-
tetanus-acellular pertussis (DTPa) and Haemophilus influenzae type b conjugate (Hib) …
tetanus-acellular pertussis (DTPa) and Haemophilus influenzae type b conjugate (Hib) …
Immunogenicity, reactogenicity and safety of a combined DTPa-IPV vaccine compared with separate DTPa and IPV vaccines in healthy Korean infants
CH Kim, SH Cha, SM Shin, CS Kim… - Korean Journal of …, 2010 - synapse.koreamed.org
Purpose To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-
acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix™ IPV …
acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix™ IPV …
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP–IPV) compared to separate administration …
SY Lee, HS Hwang, JH Kim, HH Kim, HS Lee… - Vaccine, 2011 - Elsevier
This randomized trial enrolled 442 infants in the Republic of Korea to assess the
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …
Pertussis booster vaccine in China
F Zhu - Human Vaccines, 2011 - Taylor & Francis
Vaccination against diphtheria, tetanus, and pertussis (DTP) has achieved great success in
infants and younger children in China. However, pertussis booster vaccination in older …
infants and younger children in China. However, pertussis booster vaccination in older …
[PDF][PDF] Estimating the effectiveness of Tdap vaccine for preventing pertussis: evidence of rapidly waning immunity and differences in effectiveness by Tdap brand
R Koepke, JC Eickhoff, RA Ayele, AB Petit, SL Schauer… - J Infect Dis, 2014 - Citeseer
Background: We estimated tetanus-diphtheria-acellular pertussis (Tdap) vaccine
effectiveness (VE) for preventing pertussis among adolescents during a statewide outbreak …
effectiveness (VE) for preventing pertussis among adolescents during a statewide outbreak …
Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b …
U Heininger, DTPHBV The, R Sänger, JM Jacquet… - Vaccine, 2007 - Elsevier
The immunogenicity and reactogenicity of booster vaccination with GSK Biologicals'
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4–6 …
H Marshall, T Nolan, D Roberton, P Richmond… - Vaccine, 2006 - Elsevier
This study evaluated GSK's combined DTPa-IPV vaccine (Infanrix™-IPV) given as a fifth
consecutive acellular pertussis booster dose in conjunction with the second dose of MMR …
consecutive acellular pertussis booster dose in conjunction with the second dose of MMR …
Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children …
U Heininger, JD Cherry, K Stehr, S Schmitt-Grohe… - …, 1998 - publications.aap.org
Background. A household contact substudy was performed as part of a prospective, cohort
pertussis vaccine efficacy trial in Germany. Design. Infants received four doses of either the …
pertussis vaccine efficacy trial in Germany. Design. Infants received four doses of either the …